Literature DB >> 27363591

Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom.

N J Menzies-Gow1, P A Harris2, J Elliott3.   

Abstract

BACKGROUND: Certain individuals appear to be predisposed to recurrent pasture-associated laminitis. Previous studies have predominantly investigated risk factors only after disease occurrence.
OBJECTIVES: To investigate risk factors for pasture-associated laminitis prior to disease occurrence. STUDY
DESIGN: Prospective cohort study.
METHODS: Non-laminitic ponies aged ≥7 years were recruited. Body condition score (BCS), height, weight, crest height and thickness were measured and an overnight dexamethasone suppression test performed. Plasma or serum adiponectin, leptin, triglyceride, basal insulin, insulin post-dexamethasone, insulin-like growth factor 1 (IGF-1), IGF binding protein 1 (IGFBP-1), IGFBP-3, C-reactive protein, von Willebrand's factor, soluble E-selectin and P-selectin concentrations were assayed. Follow-up data were obtained from owners annually for 3 years to ascertain occurrences of veterinarian-diagnosed pasture-associated laminitis. Data were analysed by multivariate logistic regression. Receiver operating characteristic (ROC) curves analysis was performed for significant risk factors and cut-off values determined.
RESULTS: A total of 446 animals with a median (interquartile range) age of 15 (10-20) years were recruited. Of these, 50.4% were mares and 49.6% were geldings. The most common breeds were Welsh (36.4%), Shetland (17.0%) and cob (9.4%). Overall, 72.2% of animals were overweight/obese (BCS 7-9/9), 27.3% were of ideal weight (BCS 4-6/9) and 0.5% were underweight (BCS 1-3/9). After 1, 2 and 3 years, respectively, 18 (4.0%), 30 (6.7%) and 44 (9.9%) animals were reported to have had laminitis. Plasma adiponectin, and serum basal (insulin) and (insulin) post-dexamethasone levels were significantly (P ≤ 0.05) associated with laminitis occurrence cumulatively after 1, 2 and 3 years. Use of the area under the ROC curves to distinguish animals that did and did not develop laminitis showed good (basal [insulin] after 1 year), fair (all others) or poor ([insulin] post-dexamethasone) levels of accuracy. MAIN LIMITATIONS: Animals were evaluated at a single time point and biomarkers were assayed using single assays.
CONCLUSIONS: Risk factors for future laminitis prior to disease occurrence include low plasma adiponectin and high serum basal insulin or insulin post-dexamethasone concentrations.
© 2016 EVJ Ltd.

Entities:  

Keywords:  IGF-1; adiponectin; dexamethasone; horse; insulin; laminitis

Mesh:

Year:  2016        PMID: 27363591     DOI: 10.1111/evj.12606

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  19 in total

1.  Associations between endocrine disrupting chemicals and equine metabolic syndrome phenotypes.

Authors:  S A Durward-Akhurst; N E Schultz; E M Norton; A K Rendahl; H Besselink; P A Behnisch; A Brouwer; R J Geor; J R Mickelson; M E McCue
Journal:  Chemosphere       Date:  2018-11-26       Impact factor: 7.086

2.  Metabogenomics reveals four candidate regions involved in the pathophysiology of Equine Metabolic Syndrome.

Authors:  Laura Patterson Rosa; Martha F Mallicote; Maureen T Long; Samantha A Brooks
Journal:  Mol Cell Probes       Date:  2020-07-10       Impact factor: 2.365

3.  Sustained, Low-Intensity Exercise Achieved by a Dynamic Feeding System Decreases Body Fat in Ponies.

Authors:  M A de Laat; B A Hampson; M N Sillence; C C Pollitt
Journal:  J Vet Intern Med       Date:  2016-09-17       Impact factor: 3.333

4.  Repeatability of Oral Sugar Test Results, Glucagon-Like Peptide-1 Measurements, and Serum High-Molecular-Weight Adiponectin Concentrations in Horses.

Authors:  N Frank; D M Walsh
Journal:  J Vet Intern Med       Date:  2017-05-24       Impact factor: 3.333

5.  Incidence and risk factors for recurrence of endocrinopathic laminitis in horses.

Authors:  Melody A de Laat; Dania B Reiche; Martin N Sillence; James M McGree
Journal:  J Vet Intern Med       Date:  2019-04-10       Impact factor: 3.333

6.  Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.

Authors:  Melody A de Laat; Martin N Sillence; Dania B Reiche
Journal:  J Vet Intern Med       Date:  2019-01-29       Impact factor: 3.333

7.  Influence of dietary restriction and low-intensity exercise on weight loss and insulin sensitivity in obese equids.

Authors:  Nicholas J Bamford; Samantha J Potter; Courtnay L Baskerville; Patricia A Harris; Simon R Bailey
Journal:  J Vet Intern Med       Date:  2018-12-05       Impact factor: 3.333

8.  Insulin and incretin responses to grazing in insulin-dysregulated and healthy ponies.

Authors:  Danielle M Fitzgerald; Donald M Walsh; Martin N Sillence; Christopher C Pollitt; Melody A de Laat
Journal:  J Vet Intern Med       Date:  2018-12-02       Impact factor: 3.333

9.  Use of principle component analysis to quantitatively score the equine metabolic syndrome phenotype in an Arabian horse population.

Authors:  Samantha L Lewis; Heather M Holl; Maureen T Long; Martha F Mallicote; Samantha A Brooks
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

10.  Insulin dysregulation in horses with systemic inflammatory response syndrome.

Authors:  François-René Bertin; Debra Ruffin-Taylor; Allison Jean Stewart
Journal:  J Vet Intern Med       Date:  2018-05-10       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.